TERUMO ADR Aktie

>TERUMO ADR Performance

1 Woche: 0%

1 Monat: +7,7%

3 Monate: -5,9%

6 Monate: -14,5%

1 Jahr: -32,1%

laufendes Jahr: -5,9%

>TERUMO ADR Aktie

Name:

TERUMO CORP. ADR

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US88156J1051 / A0YHJ7

Symbol/ Ticker:

TUO0 (Frankfurt)

Kürzel:

FRA:TUO0, ETR:TUO0, TUO0:GR

Index:

Webseite:

https://www.terumo.co.jp/

Profil:

Terumo Corporation Unsponsored ADR is an American Depositary Receipt that represents shares of the Terumo Corporation, a Japanese medical products company, in the U.S. financial markets. The primary function of this ADR is to facilitate investment in..
>Volltext..

Marktkapitalisierung:

17400.41 Mio. EUR

Unternehmenswert:

18294.29 Mio. EUR

Umsatz:

6341.75 Mio. EUR

EBITDA:

1617.46 Mio. EUR

Nettogewinn:

744.65 Mio. EUR

Gewinn je Aktie:

0.5 EUR

Schulden:

2209.27 Mio. EUR

Liquide Mittel:

1315.39 Mio. EUR

Operativer Cashflow:

1203.5 Mio. EUR

Bargeldquote:

0.44

Umsatzwachstum:

9.67%

Gewinnwachstum:

4.22%

Dividende je Aktie:

0.08 EUR

Dividendenrendite:

1.13%

Dividendenschätzung:

1.03%

Div. Historie:

30.09.25 - 0.081960276€
31.03.25 - 0.07651129€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

TERUMO ADR, TERUMO

Letzte Datenerhebung:

05.04.26

>TERUMO ADR Kennzahlen

Aktien/ Unternehmen:

Aktien: 1475.07 Mio. St.

Frei handelbar: -

Leerverk. Aktien: -

Rückkaufquote: -0.01%

Mitarbeiter: 30689

Umsatz/Mitarb.: 0.19 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 35.89%

Bewertung:

KGV: 23.43

KGV lG: 23.21

KUV: 2.77

KBV: 2.07

PEG-Ratio: 4.94

EV/EBITDA: 11.31

Rentabilität:

Bruttomarge: 53.37%

Gewinnmarge: 11.74%

Operative Marge: 17.26%

Managementeffizenz:

Gesamtkaprendite: 6.53%

Eigenkaprendite: 9.22%

>TERUMO ADR Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>TERUMO ADR Chart & Kurs - Frankfurt

>TERUMO ADR News

19.03.26 - 10:42	Tata Elxsi Announces the Launch of a Global Offshore Development Center (ODC) for Terumo Corporation (PR Newswire)
	PUNE, India, March 19, 2026 /PRNewswire/ -- Tata Elxsi, a global leader in design and technology services, and Terumo Corporation, a global medical innovation company, today inaugurated the 'Terumo–Tata Elxsi Offshore Development Center'. This dedicated center will support the development......

13.02.26 - 14:51	Terumo reports Q3 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.02.26 - 10:24	Terumo Corporation Profit Rises In Nine Months (AFX)
	TOKYO (dpa-AFX) - Terumo Corporation (TRUMF) announced earnings for its nine months that Increased, from last yearThe company's bottom line came in at JPY109.547 billion, or JPY74.25 per share. Th......

13.02.26 - 10:12	Terumo Corp.: Rekordumsatz im dritten Quartal, Aktie gibt wegen Inflations- und Zollsorgen nach (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

13.02.26 - 08:30	Terumo Reports Higher Earnings In 9-Month; Raises FY26 Guidance (AFX)
	TOKYO (dpa-AFX) - Terumo Corp. (TRUMY, TRUMF, 4543.T), a Japanese medical technology company, on Friday reported higher net income in the nine-month period ended December 31, 2025, compared with t......

06.01.26 - 16:36	Terumo Launches SurTract Safety Syringe In US Market (AFX)
	TOKYO (dpa-AFX) - Terumo Medical Corp. (4543.T) announced on Tuesday that it will be launching its SurTract Safety Syringe in the U.S. This syringe comes with SafeR passive safety technology creat......

06.01.26 - 14:30	Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations′ SafeR® Passive Safety Technology (PR Newswire)
	- New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* - SOMERSET, N.J., Jan. 6, 2026 /PRNewswire/ -- Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, announced the US launch of its......

14.11.25 - 11:42	Terumo meldet Rekordumsatz, verfehlt aber Gewinnziel für Q2 2025 (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

12.11.25 - 15:54	Terumo reports 1H results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

12.11.25 - 08:55	Terumo Cuts Annual Net Income Outlook On Expenses, Impairment; Ups Revenue Guidance (AFX)
	TOKYO (dpa-AFX) - Terumo Corporation (TRUMF, 4543.T) on Wednesday revised down its annual net earnings outlook, mainly due to expenses related to acquisition and impairment losses. In addition, th......

12.11.25 - 08:24	Terumo Corporation Profit Advances In H1 (AFX)
	TOKYO (dpa-AFX) - Terumo Corporation (TRUMF) revealed earnings for its first half that Increased, from the same period last yearThe company's earnings came in at JPY76.897 billion, or JPY52.12 per......

29.10.25 - 20:06	Geisinger and Terumo Neuro Advance Stroke Education and Neurovascular Innovation in Recognition of World Stroke Day 2025 (PR Newswire)
	Collaboration Highlights Minimally Invasive Neurovascular Stroke Treatment and Expands Public Awareness on Early Recognition and Access to Care DANVILLE, Pa. and ALISO VIEJO, Calif., Oct. 29, 2025 /PRNewswire/ -- In honor of World Stroke Day 2025, Geisinger and Terumo Neuro, a global......

24.10.25 - 14:03	Terumo Interventional Systems Announces Its New OPUSWAVE® Dual Sensor Imaging System and DualView® Imaging Catheter Receive FDA 510(k) Clearance (PR Newswire)
	OPUSWAVE Imaging System combines OFDI and IVUS into a single catheter, providing significant potential to reduce procedural time and costs in treating coronary artery disease DualView imaging catheter offers a 150mm maximum pullback length, a 2.6 Fr. imaging profile, 6 Fr. guide......

22.10.25 - 16:43	The Blood Center in New Orleans modernizes platelet processing with FDA-cleared automation from Terumo Blood and Cell Technologies (PR Newswire)
	— Second U.S. site to deploy the Reveos ™ system, boosting platelet supply and reducing waste LAKEWOOD, Colo., Oct. 22, 2025 /PRNewswire/ -- To help address platelet shortages and streamline blood center operations, The Blood Center in New Orleans has become the second U.S. blood center......

30.09.25 - 12:03	Kenya, Uganda and Côte d′Ivoire Partner with Terumo Blood and Cell Technologies to Build Coordinated National Care Frameworks for Sickle Cell Care (PR Newswire)
	LAKEWOOD, Colo., Sept. 30, 2025 /PRNewswire/ -- In a landmark move, the Ministries of Health of Kenya and Côte d'Ivoire, together with Uganda's Joint Clinical Research Centre (JCRC) under the stewardship of the Uganda Ministry of Health, have signed three Memoranda of Understanding (MoUs)......

03.09.25 - 09:01	Terumo Neuro Unveils New SOFIA™ Flow 88 Neurovascular Aspiration Catheter Data from EMEA Demonstrating Strong Performance (PR Newswire)
	Real-World EMEA Physician Preference Data1 Demonstrates the SOFIA Flow 88 Aspiration Catheter's Trackability, Navigation, and Overall Performance in Stroke Procedures MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly......

03.09.25 - 09:01	Terumo Neuro Launches Aneurysm Treatment Alliance in EMEA to Advance Physician Collaboration and Aneurysm Care (PR Newswire)
	"Bringing Effective Solutions to Life" Through A Dedicated EMEA Initiative Designed to Simplify Collaboration, Showcase A Comprehensive Hemorrhagic Portfolio, And Empower Physicians to Improve Patient Outcomes MARSEILLE, France, Sept. 3, 2025 /PRNewswire/ -- Terumo Neuro, a global leader......

28.08.25 - 06:30	Japan′s Terumo justifies $1.5bn organ transplant deal after share slide (Nikkei)
	Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

25.08.25 - 10:54	Japan′s Terumo to Buy British Firm for Organ Transplant Biz (Nippon)
	Tokyo, Aug. 25 (Jiji Press)--Japanese medical equipment maker Terumo Corp. said Monday that it will fully acquire OrganOx Ltd., a British maker of equipment to preserve organs for transplantation, for 1.5 billion dollars. The acquisition will allow Terumo to make a full-fledged entry into the organ transplantation market, which is forecast to grow. Set up in 2008 as a spinoff from the Uni......

25.08.25 - 10:30	Terumo to buy OrganOx for $1.5bn to enter organ transplant market (Nikkei)
	Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram